Medivolve Inc.
MEDVF
$0.002
$0.000.00%
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 669.00K | 508.90K | 590.40K | 697.70K | -12.06M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 669.00K | 508.90K | 590.40K | 697.70K | -12.06M |
| Cost of Revenue | 104.30K | 110.80K | 83.10K | 135.10K | -7.57M |
| Gross Profit | 564.70K | 398.10K | 507.30K | 562.60K | -4.50M |
| SG&A Expenses | 2.70M | 2.93M | 4.00M | 4.15M | 5.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.81M | 3.04M | 4.08M | 4.28M | -2.05M |
| Operating Income | -2.14M | -2.54M | -3.49M | -3.58M | -10.01M |
| Income Before Tax | -2.21M | -2.91M | -4.16M | -4.91M | -11.47M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.21 | -2.91 | -4.16 | -4.91 | -11.33 |
| Earnings from Discontinued Operations | -8.71M | -9.42M | -4.91M | -6.78M | -6.03M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 193.60K | 140.40K | 100.60K | -- | -- |
| Net Income | -10.72M | -12.18M | -8.96M | -11.68M | -15.10M |
| EBIT | -2.14M | -2.54M | -3.49M | -3.58M | -10.01M |
| EBITDA | -1.99M | -2.30M | -3.26M | -2.85M | -9.10M |
| EPS Basic | -0.40 | -0.45 | -0.33 | -0.43 | -0.56 |
| Normalized Basic EPS | -0.05 | -0.06 | -0.08 | -0.09 | -0.24 |
| EPS Diluted | -0.40 | -0.45 | -0.33 | -0.43 | -0.56 |
| Normalized Diluted EPS | -0.05 | -0.06 | -0.08 | -0.09 | -0.24 |
| Average Basic Shares Outstanding | 108.08M | 108.08M | 108.07M | 108.07M | 108.07M |
| Average Diluted Shares Outstanding | 108.08M | 108.08M | 108.07M | 108.07M | 108.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |